Antifungal Innate Immunity.

4区 医学 Q2 Biochemistry, Genetics and Molecular Biology
Sarah Sze Wah Wong, Sarah Dellière, Mathieu Lepas, Vishukumar Aimanianda
{"title":"Antifungal Innate Immunity.","authors":"Sarah Sze Wah Wong, Sarah Dellière, Mathieu Lepas, Vishukumar Aimanianda","doi":"10.1007/978-3-031-85340-1_9","DOIUrl":null,"url":null,"abstract":"<p><p>Despite being common inhabitants of human barrier surfaces (skin, oral cavity, gut, lungs, vagina), diseases caused by fungi are rare owing to their surveillance by and sentinel function of human innate immune system. Whereas a compromised or suppressed immunity facilitates the establishment of fungal infections, the consequence of which ranges from superficial infections affecting life quality to life-threatening invasive fungal diseases. Over the last few decades, the number of people at risk for invasive fungal infections has increased due to immunosuppressive medical interventions. Also, there is an alarming increase in incidence of antifungal drug resistance, which demands alternative antifungal strategies. In vivo experimental studies have indicated that immunotherapies could be promising to combat fungal pathogens. Nevertheless, development of an effective clinical immunotherapy requires in-depth knowledge on pathobiology of fungi and the consequent host responses. Here is an overview of the defense mechanisms exerted by the human innate immune system against fungal pathogens, counteracting virulence mechanisms associated with these fungal pathogens and the innate immune system-based antifungal therapeutic strategies developed so far.</p>","PeriodicalId":7270,"journal":{"name":"Advances in experimental medicine and biology","volume":"1476 ","pages":"225-250"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in experimental medicine and biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/978-3-031-85340-1_9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Despite being common inhabitants of human barrier surfaces (skin, oral cavity, gut, lungs, vagina), diseases caused by fungi are rare owing to their surveillance by and sentinel function of human innate immune system. Whereas a compromised or suppressed immunity facilitates the establishment of fungal infections, the consequence of which ranges from superficial infections affecting life quality to life-threatening invasive fungal diseases. Over the last few decades, the number of people at risk for invasive fungal infections has increased due to immunosuppressive medical interventions. Also, there is an alarming increase in incidence of antifungal drug resistance, which demands alternative antifungal strategies. In vivo experimental studies have indicated that immunotherapies could be promising to combat fungal pathogens. Nevertheless, development of an effective clinical immunotherapy requires in-depth knowledge on pathobiology of fungi and the consequent host responses. Here is an overview of the defense mechanisms exerted by the human innate immune system against fungal pathogens, counteracting virulence mechanisms associated with these fungal pathogens and the innate immune system-based antifungal therapeutic strategies developed so far.

抗真菌先天免疫。
尽管真菌是人体屏障表面(皮肤、口腔、肠道、肺、阴道)的常见居民,但由于真菌具有人体先天免疫系统的监视和哨兵功能,因此真菌引起的疾病很少发生。然而,免疫力受损或抑制有助于真菌感染的建立,其后果从影响生活质量的表面感染到危及生命的侵袭性真菌疾病。在过去的几十年里,由于免疫抑制医学干预,侵袭性真菌感染风险的人数增加了。此外,抗真菌药物耐药性的发生率也在惊人地增加,这需要替代的抗真菌策略。体内实验研究表明,免疫疗法有望对抗真菌病原体。然而,开发一种有效的临床免疫疗法需要深入了解真菌的病理生物学和随之而来的宿主反应。本文概述了人类先天免疫系统对真菌病原体的防御机制、与这些真菌病原体相关的抗病毒机制以及迄今为止基于先天免疫系统的抗真菌治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in experimental medicine and biology
Advances in experimental medicine and biology 医学-医学:研究与实验
CiteScore
5.90
自引率
0.00%
发文量
465
审稿时长
2-4 weeks
期刊介绍: Advances in Experimental Medicine and Biology provides a platform for scientific contributions in the main disciplines of the biomedicine and the life sciences. This series publishes thematic volumes on contemporary research in the areas of microbiology, immunology, neurosciences, biochemistry, biomedical engineering, genetics, physiology, and cancer research. Covering emerging topics and techniques in basic and clinical science, it brings together clinicians and researchers from various fields.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信